The stock of IGC Pharma Inc (AMEX: IGC) has increased by 1.18 when compared to last closing price of 0.43.Despite this, the company has seen a gain of 10.55% in its stock price over the last five trading days. businesswire.com reported 2024-08-08 that POTOMAC, Md.–(BUSINESS WIRE)– #AD–IGC Pharma Reports First Quarter Fiscal 2025 Results.
Is It Worth Investing in IGC Pharma Inc (AMEX: IGC) Right Now?
Additionally, the 36-month beta value for IGC is 1.29. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for IGC is 52.02M and currently, short sellers hold a 2.25% ratio of that float. The average trading volume of IGC on August 15, 2024 was 227.21K shares.
IGC’s Market Performance
IGC stock saw a decrease of 10.55% in the past week, with a monthly decline of -5.00% and a quarterly a decrease of -24.56%. The volatility ratio for the week is 5.84%, and the volatility levels for the last 30 days are 5.99% for IGC Pharma Inc (IGC). The simple moving average for the past 20 days is -0.92% for IGC’s stock, with a 11.51% simple moving average for the past 200 days.
IGC Trading at -1.14% from the 50-Day Moving Average
After a stumble in the market that brought IGC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -52.49% of loss for the given period.
Volatility was left at 5.99%, however, over the last 30 days, the volatility rate increased by 5.84%, as shares sank -12.20% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.02% lower at present.
During the last 5 trading sessions, IGC rose by +8.01%, which changed the moving average for the period of 200-days by +45.52% in comparison to the 20-day moving average, which settled at $0.4333. In addition, IGC Pharma Inc saw 54.32% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IGC starting from PRINS RICHARD K, who proposed sale 200,000 shares at the price of $0.39 back on Aug 12 ’24. After this action, PRINS RICHARD K now owns shares of IGC Pharma Inc, valued at $78,200 using the latest closing price.
Stock Fundamentals for IGC
Current profitability levels for the company are sitting at:
- -9.47 for the present operating margin
- 0.34 for the gross margin
The net margin for IGC Pharma Inc stands at -12.53. The total capital return value is set at -1.24. Equity return is now at value -126.20, with -101.29 for asset returns.
Based on IGC Pharma Inc (IGC), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -20.16.
Currently, EBITDA for the company is -5.82 million with net debt to EBITDA at 0.17. When we switch over and look at the enterprise to sales, we see a ratio of 28.87. The receivables turnover for the company is 37.93for trailing twelve months and the total asset turnover is 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.77.
Conclusion
In conclusion, IGC Pharma Inc (IGC) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
